These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32014819)

  • 1. A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models.
    Achek A; Kwon HK; Patra MC; Shah M; Hong R; Lee WH; Baek WY; Choi YS; Kim GY; Pham TLH; Suh CH; Kim W; Hahm DH; Choi S
    EBioMedicine; 2020 Feb; 52():102645. PubMed ID: 32014819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides.
    Couture LA; Piao W; Ru LW; Vogel SN; Toshchakov VY
    J Biol Chem; 2012 Jul; 287(29):24641-8. PubMed ID: 22648407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza.
    Piao W; Shirey KA; Ru LW; Lai W; Szmacinski H; Snyder GA; Sundberg EJ; Lakowicz JR; Vogel SN; Toshchakov VY
    Cell Rep; 2015 Jun; 11(12):1941-52. PubMed ID: 26095366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The αC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases.
    Shah M; Kim GY; Achek A; Cho EY; Baek WY; Choi YS; Lee WH; Kim DJ; Lee SH; Kim W; Kim SS; Cheong JY; Suh CH; Choi S
    Biomaterials; 2020 Jul; 245():119974. PubMed ID: 32220799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting TLR4 signaling by TLR4 Toll/IL-1 receptor domain-derived decoy peptides: identification of the TLR4 Toll/IL-1 receptor domain dimerization interface.
    Toshchakov VY; Szmacinski H; Couture LA; Lakowicz JR; Vogel SN
    J Immunol; 2011 Apr; 186(8):4819-27. PubMed ID: 21402890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach.
    Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC
    J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Small-Molecule Inhibitor of Endosomal TLRs Reduces Inflammation and Alleviates Autoimmune Disease Symptoms in Murine Models.
    Patra MC; Achek A; Kim GY; Panneerselvam S; Shin HJ; Baek WY; Lee WH; Sung J; Jeong U; Cho EY; Kim W; Kim E; Suh CH; Choi S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
    Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
    Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis.
    Sacre SM; Andreakos E; Kiriakidis S; Amjadi P; Lundberg A; Giddins G; Feldmann M; Brennan F; Foxwell BM
    Am J Pathol; 2007 Feb; 170(2):518-25. PubMed ID: 17255320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ
    Fitzpatrick JM; Minogue E; Curham L; Tyrrell H; Gavigan P; Hind W; Downer EJ
    J Neuroimmunol; 2020 Jun; 343():577217. PubMed ID: 32244040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
    Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
    J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brazilian Red Propolis Attenuates Inflammatory Signaling Cascade in LPS-Activated Macrophages.
    Bueno-Silva B; Kawamoto D; Ando-Suguimoto ES; Alencar SM; Rosalen PL; Mayer MP
    PLoS One; 2015; 10(12):e0144954. PubMed ID: 26660901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
    Toshchakov VU; Basu S; Fenton MJ; Vogel SN
    J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
    O'Neill LA
    Curr Opin Pharmacol; 2003 Aug; 3(4):396-403. PubMed ID: 12901949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
    Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
    J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.